The Seventh Conference on Retroviruses and Opportunistic Infections.
Merrick
S
S
Weill Medical College of Cornell University, New York, USA.
Gulick
R
R
Boyle
B
B
D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial / Q000235:genetics; D004359:Drug Therapy, Combination; D005260:Female; D005838:Genotype; D017408:Guidelines as Topic; D015658:HIV Infections / Q000188:drug therapy / Q000635:transmission; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D010641:Phenotype; D011247:Pregnancy; D012190:Retroviridae / Q000187:drug effects / Q000235:genetics; D012192:Retroviridae Infections / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D012737:Sex Factors; D015163:Superinfection / Q000188:drug therapy; D019562:Viral Load
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors